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Schwann cell reprogramming and differentiation are crucial prerequisites for neuronal
regeneration and re-myelination to occur following injury to peripheral nerves. The
neurotrophin receptor p75NTR has been identified as a positive modulator for Schwann
cell myelination during development and implicated in promoting nerve regeneration
after injury. However, most studies base this conclusion on results obtained from
complete p75NTR knockout mouse models and cannot dissect the specific role of
p75NTR expressed by Schwann cells. In this present study, a conditional knockout
model selectively deleting p75NTR expression in Schwann cells was generated, where
p75NTR expression is replaced with that of an mCherry reporter. Silencing of Schwann
cell p75NTR expression was confirmed in the sciatic nerve in vivo and in vitro, without
altering axonal expression of p75NTR. No difference in sciatic nerve myelination during
development or following sciatic nerve crush injury was observed, as determined by
quantification of both myelinated and unmyelinated nerve fiber densities, myelinated
axonal diameter and myelin thickness. However, the absence of Schwann cell p75NTR
reduced motor nerve conduction velocity after crush injury. Our data indicate that the
absence of Schwann cell p75NTR expression in vivo is not critical for axonal regrowth or
remyelination following sciatic nerve crush injury, but does play a key role in functional
recovery. Overall, this represents the first step in redefining the role of p75NTR in the
peripheral nervous system, suggesting that the Schwann cell-axon unit functions as a
syncytium, with the previous published involvement of p75NTR in remyelination most
likely depending on axonal/neuronal p75NTR and/or mutual glial-axonal interactions.
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INTRODUCTION
Schwann cells are axon-ensheathing glial cells of the peripheral
nervous system (PNS) and are essential in maintaining normal
nerve function as well as facilitating nerve repair following
injury. Two subtypes of Schwann cells exist in the adult
PNS, either myelinating or non-myelinating. The myelinating
Schwann cells form a multi-layered myelin sheath around a
segment of a single large-caliber axon, spirally wrapping its
plasma membrane around the axon. In contrast, non-myelinating
Schwann cells surround and segregate groups of several small-
diameter nociceptive axons, in a structure called Remak bundles.
The development of the PNS into these organized structures
has been extensively studied and the identification of essential
molecules and signaling pathways established (Jessen and Mirsky,
2005; Richner et al., 2014; Gonçalves et al., 2017). An important
group in this context is the family of neurotrophins consisting
of nerve growth factor (NGF), brain derived neurotrophic factor
(BDNF), neurotrophin-3 (NT-3) and neurotrophin-4/5 (NT-4/5),
which binds to two structurally unrelated receptors: the p75
neurotrophin receptor (p75NTR) and the tropomyosin receptor
kinases (TrkA, -B, and -C). It is generally well accepted that
binding of neurotrophins to the Trk receptors mediate survival
and differentiation, but the specific functions of p75NTR in the
PNS remains elusive. The controversy may partly be attributed
to the fact that p75NTR is expressed by both neuronal and
glial cell types and furthermore may have very different and
even contradictory roles depending on cell type and temporal
expression pattern, including survival signaling, cytoskeletal
organization as well as the induction of cell death (Chao,
2003; Reichardt, 2006; Meeker and Williams, 2015), providing
substantial cellular and molecular diversity of this receptor.
Damage to adult peripheral nerves causes axonal degene-
ration, myelin degradation and Schwann cell dedifferentiation
distal to the injury site in the process of Wallerian degeneration.
Interestingly, such injury also induces mechanisms at the cellular
level resembling those active during development, including
increased neurotrophin synthesis in neurons and Schwann cells
which, which is important for guiding and supporting axonal
regeneration (Richner et al., 2014). It is well established that
p75NTR is expressed by Schwann cells during development and
following peripheral nerve injury (Taniuchi et al., 1986; Johnson
et al., 1988), where a high expression level is maintained until
contact between the (re)growing axons and Schwann cells have
been established and (re)myelination initiated (Johnson et al.,
1988). In line with this, studies using complete p75NTR knockout
(KO) mouse models have found that the lack of p75NTR results
in reduced PNS myelination (Cosgaya et al., 2002). However, the
mechanism by which p75NTR affects nerve regeneration following
injury is unclear. p75NTR has been reported to inhibit motor
axonal regeneration (Boyd and Gordon, 2001), be indispensable
for motor axonal regrowth (Gschwendtner et al., 2003), to be
important for regeneration and remyelination of motor neurons
(Tomita et al., 2007), and important for both the number
and regrowth of axons in a mixed nerve (Song et al., 2006,
2009). A central tool for the majority of previous studies
investigating the role of p75NTR in the PNS has been the
complete p75NTR KO mouse models, the exon III deletion (Lee
et al., 1992) and the subsequent exon IV model (von Schack
et al., 2001). These KO models demonstrate a dramatic PNS
phenotype, with an approximately 40–50% reduction in DRG
neurons and myelinated axon numbers as well as impaired
levels of myelination (Cosgaya et al., 2002). Importantly, these
models exhibit loss of p75NTR in Schwann cells, DRG- and
motor neurons and the use of such models cannot therefore
clarify whether the observed phenotypes result from loss of
p75NTR in the Schwann cells, a neuronal subpopulation or
both. To complicate matters further, it has subsequently been
determined that both models are not complete KOs but retain
the expression of an alternative active splice variant (exon III
model) or results in a pro-apoptotic fragment (exon IV model)
(von Schack et al., 2001; Murray et al., 2003; Paul et al., 2004).
In this study, to dissect the role of p75NTR signaling in Schwann
cells in the process of nerve regeneration and remyelination
following nerve crush injury, we have developed a conditional
KO model selectively deleting p75NTR expression in Schwann
cells. Our results show that p75NTR deletion in Schwann cells
does not affect the structure of the uninjured myelinated or
unmyelinated fibers. In response to injury, although axonal
regeneration and remyelination appeared unaffected in Schwann
cell p75NTR deficient animals, these mice nonetheless exhibited
reduced recovery of motor nerve conduction velocity.
MATERIALS AND METHODS
Mouse Model Generation
To generate mice with conditional deletion of p75NTR in
Schwann cells, p75fl/fl mice (Boskovic et al., 2014) were crossed
to transgenic mice containing the myelin protein zero promoter
driving expression of Cre recombinase (Mpz-cre) (sourced from
the Jackson Laboratory strain #017927) (Feltri et al., 1999). Upon
recombination, the p75NTR genomic DNA flanked by the loxP
sites is inverted and, in p75in/in cells, expression of p75NTR
is replaced by expression of mCherry (Boskovic et al., 2014).
The resulting knockout mice were termed p75in/in Mpz-cre
(referred to as SC-p75NTR-KO throughout this manuscript). All
mice were on a C57BL/6 background and housed in specific
pathogen-free conditions at the Melbourne Brain Centre Animal
Facility (The Royal Melbourne Hospital, Australia). Animal
breeding procedures were approved by The Florey Institute for
Neuroscience and Mental Health Animal Ethics Committee and
followed the Australian Code of Practice for the Care and Use of
Animals for Scientific Purposes.
Mouse Surgery
For the mouse model of injury, 8–10-week-old female SC-
p75NTR-KO and p75NTRfl/fl Cre- (control littermates) were used.
By this age, the PNS is already mature and injury effects will
not be misinterpreted by the developmental process. Anesthesia
was induced with isoflurane and a subcutaneous injection of
buprenorphine and ampicillin administered prior to surgery, to
minimize pain and post-surgical distress. The thigh and legs
were shaved, eyes protected from drying and the sciatic nerve
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exposed at the mid-thigh level by separating the biceps femoris
and the gluteus superficialis. After carefully clearing surrounding
connective tissue, the left sciatic nerve was crushed with a
non−serrated clamp, twice for 15 s. A sham operation was
performed similarly at the contralateral side, where the sciatic
nerve was exposed and the skin closed immediately after. In both
situations, the musculature was prepared with minimum tissue
damage to guarantee the ideal conditions for functional recovery.
Mice were cared for in a pathogen-free environment, in a
12 h light/dark cycle and with water and food ad libitum. One
group of animals was euthanized at post-injured day 15 (n = 4
littermates, n = 6 SC-p75NTR-KO) while the other group was
sacrificed 29 days after injury (n = 8 littermates, n = 6 SC-p75NTR-
KO). Animals were handled according to the European Union
Council Directive and National rules.
Sensorimotor Analysis
Sensorimotor behavior was analyzed before (0) and 1, 5, 7, 14,
and 28 days after injury.
Mechanical allodynia was assessed with the application of
a set of calibrated Von Frey filaments (Touch-Test
R©
Sensory
Evaluators, North Coast Medical, CA, United States) into the
midplantar side of the hind paw until the filament was just bent
(bending forces from 0.2 to 2 g). Mice were placed in a Plexiglas
cage with mesh flooring and allowed to acclimate for 1 h. The
stimulus was repeated five times with each filament and a positive
response in three out of five repetitive stimulations stated as the
pain threshold. The withdrawal threshold is expressed in grams.
The Hargreaves test was used to measure paw withdrawal
latency to a noxious thermal stimulus using a Heat Flow I.R,
Radiometer (Hargreaves Apparatus, Cat. #37370, Ugo Basile,
Gemonio, Italy). The radiant heat source was kept at 50%
(190 mW/cm2) in all tested animals that were let to acclimatize
for 1 h before the procedure. Hind paws were tested alternately
with 5 min between consecutive tests, and five measurements
were obtained for each side, that were averaged for a final result.
A cut-off of 20 s was established to avoid potential burn injury.
Walking tract analysis was performed to access locomotor
functional recovery. Briefly, the mice hind feet were pressed
onto a non-toxic ink pad and animals were then allowed to
walk through a dark corridor over an A3 white printer paper.
The obtained footprints were then measured to calculate the
sciatic functional index (SFI) using the empirical equation
adapted for mice by Inserra et al. (1998): SFI = 118.9 × [(ETS-
CTS)/CTS] − 51.2 × [(EPL-CPL)/CPL] − 7.5, where ETS
represents operated experimental toe spread (distance between
the first and fifth toes), CTS stands for control toe spread, EPL
for operated experimental print length and CPL for control print
length (Inserra et al., 1998). Footmarks made at the beginning of
the trial were excluded and three analyzable walks were evaluated
from each run, for individual step parameter calculation. The
pre-injured SFI values (time point = 0) were used as control
for comparison. The SFI scores that we processed ranged from
0 to −130, with 0 representing normal or completely recovered
nerve function and −100 or more, a non-functional nerve;
thus, mice that dragged their toes were arbitrarily assigned a
value of−100.
Nerve Conduction Velocities
Motor (sciatic) and sensory (sural) nerve conduction velocities
(NCV) were performed in naïve mice and 29 days injured
ones, according to (Oh et al., 2010) using a Viking Quest
apparatus (Natus Neurology Incorporated, United States).
Briefly, for sural nerve, recording electrodes were placed in
the dorsal part of the foot, with supramaximal stimulation
at the ankle. Sural sensory NCV (m/s) was calculated by
dividing the distance between the recording and stimulating
electrodes (mm) by the onset latency (ms) of the sensory nerve
action potential after supramaximal antidromic stimulation.
Sciatic-tibial motor NCV was recorded by placing electrodes
dorsally in the foot and orthodromically stimulating first at
the ankle, then at the sciatic notch. The distance between
the two sites of stimulation (mm) was then divided by the
difference between the two onset latencies (ankle distance
and notch distance, ms) to calculate the final sciatic-tibial
motor NCV (m/s).
Immunohistochemistry and Microscopy
Naïve P11 mice were perfused transcardially with 4%
paraformaldehyde (PFA), sciatic nerves isolated, frozen and
10 µm cryosections collected. For tissue imaging, frozen
sections were incubated with primary antibodies directed against
p75NTR (G323A, Promega), βIII-tubulin (G7121, Promega)
and contactin-associated protein 1 (Caspr, a kind gift from
Professor Elior Peles, Weizmann Institute of Science, Israel),
diluted in blocking buffer containing 10% FBS and 0.3% Triton
X100 in PBS. Incubation with proper fluorophore-conjugated
secondary antibodies (Invitrogen) was followed. PBS was then
used to wash the sections that were finally mounted in DAKO
mounting medium containing DAPI. Three animals per group
were evaluated, and images captured by confocal microscopy
(LSM 780, Carl Zeiss, Germany).
Western Blot Analysis
Sciatic nerves from adult control littermates (n = 6) and SC-
p75NTR-KO (n = 6) mice were dissociated in lysis buffer
(2 mM CaCl2, 1 mM MgCl2, 10 mM HEPES, 140 mM
NaCl and 1% Triton X-100, pH 7.8, with protease inhibitors
from Roche) and centrifuged at 10.000 × g for 10 min at
4◦C. Total protein concentration was determined using the
Bicinchoninic Acid kit from Sigma. Protein lysates were run
on 12% SDS-PAGE (20 µg/lane) and electro-blotted for 1.5 h
onto polyvinylidenedifluoride (PVDF) filters (Amersham) in
192 mM glycine, 25 mM Tris–HCl, pH 8.0. Membranes were
then blocked and incubated overnight at 4◦C with the primary
antibodies: rabbit anti-p75NTR (1:500, Promega, Cat. #G323A)
and mouse anti-β-actin (1:5000, Sigma, Cat. #A5441). Following
a washing step, membranes were incubated with horseradish
peroxidase (HRP)-conjugated secondary antibodies (1:1000,
swine anti-rabbit, Dako, Cat. # P0217; rabbit anti-mouse, Dako
# P0260) and blots visualized with the Amersham ECL plus
western blotting detection reagents (GE Healthcare) and Fuji
film LAS1000. Densitometry was performed with QuantityOne
software (Bio-Rad).
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Morphological and Morphometric
Analysis
Nerve samples were processed for morphological and morpho-
metrical analysis of myelinated and unmyelinated nerve fibers.
Fixation of nerve samples was carried out using 2.5% purified
glutaraldehyde and 0.5% sucrose in 0.1M Sorensen phosphate
buffer for 2–4 h. Samples were subsequently post-fixed in
2% osmium tetroxide for 2 h at 4◦C and dehydrated in a
sequence of ethanol from 30 to 100%. After being cleared
in propylene oxide, samples were embedded in Glauerts’
embedding mixture of resins containing equal parts of Araldite
M and Araldite Harter, HY 964 (Merck, Darmstad, Germany),
including 0.5% of the plasticizer dibutyl phthalate and
1–2% of the accelerator 964, DY 064 (Merck). For high-
resolution light microscopy, semi-thin transverse sections
(2.5 µm) were cut in a Leica Ultracut UCT ultramicrotome
(Leica Microsystems, Wetzlar, Germany) and stained with
Toluidine blue. Stereology was performed in a DM4000B
microscope equipped with a DFC320 digital camera and an
IM50 image manager system (Leica Microsystems, Wetzlar,
Germany). Systematic random sampling and D-dissector
were adopted using a protocol previously described (Geuna
et al., 2000, 2004). Total number of myelinated fibers,
axon and fiber size, myelin thickness and g-ratio were
then determined.
For electron microscopy, ultrathin sections (70 nm thickness)
were cut by using an ultramicrotome Leica EM UC7 (Leica,
Wien, Austria). Sections were collected onto formvar-coated slot
grids and counterstained with uranyl acetate and lead citrate.
A 100 kV transmission electron microscope (EM JEM 1230, JEOL
Ltd., Tokyo, Japan) was used for qualitative and quantitative
examination of the samples. For C-fiber counting, we started at
one corner of the fascicle and acquired images of every third
microscopic field with 15,000× magnification until 35 images
were photographed. C-fibers in the images were counted and
their density calculated.
Schwann Cell Cultures Derived From
Sciatic Nerves of Adult Mice
Schwann cell cultures from adult mouse sciatic nerves were
prepared as described by Wang and colleagues (Wang et al.,
2013), with some alterations to the protocol. In brief, n = 16
littermates and n = 16 SC-p75NTR-KO mice were sacrificed
by cervical dislocation prior to sciatic nerve dissection into
L-15 medium. The dissected nerves were rinsed in PBS and
incubated in Schwann cell culture medium [SCCM; DMEM
supplemented with 10% FBS, 2 µM forskolin (Sigma, Cat.
#F6886), 10 ng/mL human heregulin-β1 (R&D Systems, Cat.
#396-HB) and 50 ng/mL b-FGF (PeproTech, Cat. #100-18B)]
for 1 week at 37◦C and 5% CO2. The media was changed every
2 days. Nerves were then cut into approximately 2 mm and
digested for 40 min with a mixture of 0.2% collagenase NB4
Standard Grade (Nordmark Biochemicals, Cat. #S1745402) and
0.2% dispase (Sigma, Cat. #D4693) at 37◦C and subsequently
triturated and plated onto poly-L-lysine coated 60 mm dishes
and incubated for 2 days in SCCM. The mixed cultures where
then trypsinized and plated on coverslips at a density of 100,000
cells/coverslip and cultured for additional 2 days before fixation
in 4% PFA for further processing.
Immunocytochemistry and Microscopy
of Schwann Cell Cultures
The fixed Schwann cell cultures were permeabilized with PBS
containing 0.1% Triton-X 100 for three times 10 min and
subsequently incubated in PBS containing 5% donkey serum
and 1% BSA to block unspecific binding of the antibodies. The
cells were incubated with rabbit anti-p75NTR [1:1500, (Huber
and Chao, 1995), Cat. #9651] diluted in PBS containing 1%
BSA overnight at 4◦C. The samples were incubated 1 h at room
temperature the following day before three times 10 min wash
in PBS and 4 h incubation with AlexaFlour488 donkey anti-
rabbit IgG (H+L) (1:300, Life Technologies, #A21206) diluted
in PBS containing 1% BSA. After three times 10 min washing,
Hoechst 33258 was used for nuclear staining (1:10.000, Sigma).
Sections were then mounted with Dako Fluorescent mounting
medium and sealed with nail polish. Images were acquired
with a ZEISS Axio Imager 2 microscope (Carl Zeiss, Germany)
equipped with a Hamamatsu digital camera (ORCA-flash4.0
digital camera, model C11440-22CU, Hamamatsu Photonics
Deutchland GmbH, Germany) and subsequent image analysis
performed with ImageJ.
Statistical Analysis
Statistical comparison of data was accomplished using the
Student t-test or One/Two-way ANOVA followed by Bonferroni
post-test, with Graph Pad Prism software. Quantitative data is
reported as mean ± SEM. Statistical significance was established
for p∗ < 0.05, p∗∗ < 0.01, p∗∗∗ < 0.001.
RESULTS
Targeted Disruption of p75NTR
in Schwann Cells
To generate an in vivo model appropriate for investigating the
involvement of Schwann cell-expressed p75NTR in peripheral
myelination, we developed mice with selective deletion of
p75NTR in Schwann cells. For this purpose, mice harboring
loxP recognition sites in the Ngfr gene (Boskovic et al., 2014)
were crossed with transgenic mice in which Cre recombinase
is expressed under the control of the Myelin Protein Zero
(P0) promoter (Feltri et al., 1999), to finally produce SC-
p75NTR-KO mice. The P0 promoter becomes active in Schwann
cell precursors at embryonic day 13.5–14.5, which includes
cells that develop into both myelinating and non-myelinating
Schwann cells but excludes other glial cells and dorsal root
ganglion neurons (Feltri et al., 1999, 2002). Therefore, upon
introduction of Cre recombinase (as heterozygote Cre+/−),
the Ngfr genomic DNA flanked by loxP sites is inverted and
expression of p75NTR in Schwann cells is replaced with that of
mCherry, while Cre-negative (Cre−/−) littermate controls have
unchanged p75NTR expression (Figure 1A). Immunofluorescent
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FIGURE 1 | Continued
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FIGURE 1 | P75NTR inactivation in Schwann cells. (A) Double-label immunofluorescence microscopy of p75NTR (green) and βIII-tubulin (pink) in P11 sciatic nerve of
SC-p75NTR-KO and WT littermates. mCherry emitting fluorescence was identified in channel 568. Nuclei are labeled with Hoechst (blue). The overlap of tubulin and
p75NTR reflects axonal p75NTR (white). Note that in the WT, there is a noticeable amount of p75NTR staining that does not overlap with tubulin (green color in the
merge), possibly due to p75NTR expression in Schwann cells. Images represent n = 4 mice/group; scale bar 25 µm. (B) Fluorescence images of cells that were
primary cultured from adult mice sciatic nerves, fixed and stained with an antibody against p75NTR (green). mCherry 568 fluorescence was observed in Schwann
cells from SC-p75NTR-KO but not WT littermates. In the merge panel, it is clear that p75NTR was only present in Schwann cells and not fibroblasts from the WT
nerves (cells with bigger nuclei displayed with Hoechst, blue), being completely absent in the SC-p75NTR-KO. Scale bar 10 µm; n = 16 mice/group. (C) P75NTR was
determined by immunoblot analysis in extracts of sciatic nerves isolated from adult mice. Quantification of p75NTR ratios by densitometry against levels of β-actin.
Data represent the mean ± SEM for six mice/genotype (∗∗∗p < 0.001 compared with littermate controls). (D) Immunofluorescence microscopy of Caspr (green) in
naïve P11 sciatic nerves. Note similar intensity and distribution of immunoreactivity throughout the tissue in both genotypes. Nuclei are identified with DAPI (blue) and
mCherry visualized in the red channel in SC-p75NTR-KO mice. Scale bar, 50 µm; n = 4 mice/group.
staining of sciatic nerves demonstrated a significant amount of
p75NTR immunostaining in axons of both SC-p75NTR-KO or
littermate controls (Figure 1A), confirming that SC-p75NTR-KO
mice continuously express p75NTR in peripheral neurons/axons.
To further substantiate that the inversion strategy resulted in
loss of p75NTR protein in Schwann cells, we prepared Schwann
cell primary cultures from adult mice. Our results clearly
confirmed that SC-p75NTR-KO derived Schwann cells presented
red mCherry fluorescent signal and no p75NTR immunostaining,
with contrary observations in Schwann cells isolated from
the littermate controls (Figure 1B). Western blot analysis
of lysates isolated from whole sciatic nerves demonstrated
an approximately 30% reduction of p75NTR expression in
SC-p75NTR-KO nerves relative to littermate control nerves
(Figure 1C), revealing that the majority of p75NTR protein in
adult mouse sciatic nerves is expressed by other cell types,
primarily neurons (axons). We did not detect any evidence of
altered Mendelian ratios of the SC-p75NTR-KO mice relative
to littermate controls, and deviation in size or weight was
not found between adult mice of different genotypes (data
not shown). Finally, there were no indication of any overt
neurological abnormalities in the SC-p75NTR-KO mice, and
Caspr immunostaining in developing nerve (at P11) did not
reveal any differences between paranodal junctions in myelinated
fibers between genotypes (Figure 1D).
SC-p75NTR-KO Mice Exhibit Mild
Behavioral Defects After Nerve Injury
To investigate the sensorimotor phenotype of SC-p75NTR-
KO mice, we initially evaluated sensory profiles by von
Frey filaments (mechanical sensitivity) and Hargreaves test
(thermal/heat sensitivity), as well as motor recovery by walking
tract analysis. Tests were performed as pre-injury baseline (time
point = 0) and at 1, 7, 14, 21, and 28 days following sciatic
crush injury. Baseline levels were equivalent between sham-
operated SC-p75NTR-KO and littermate controls for both Von
Frey and Hargreaves tests (Figures 2A,B). As expected, both
genotypes demonstrated reduced sensitivity from day 1 post-
injury, confirming destruction of sensory axons by the crush
procedure. Mechanical sensitivity increased over the following
period for both genotypes, likely reflecting axonal regeneration
and accompanying reinnervation of target tissues. The recovery
profile was largely identical for the two genotypes, reaching
baseline levels at day 14 and with a non-significant tendency
of increased sensitivity in the injured paw. For the SC-p75NTR-
KO we observed a small but significant transient decrease in
mechanical threshold at day 21 (relative to the contralateral
uninjured paw), however, this effect was absent at day 28
(Figure 2A). Hargreaves test demonstrated a pattern largely
identical to that of the von Frey test; 1-day after injury, both SC-
p75NTR-KO mice and littermate controls experienced reduced
sensitivity to heat-induced noxious stimulus that recovered to
baseline levels by day 7. We again observed a transient reduction
in sensitivity 21 days following nerve crush in the SC-p75NTR-
KO mice, which was absent by day 28 (Figure 2B). Recovery of
motor function was determined by assessing the SFI at the same
time points as for the sensory tests. No differences were found
at day 0 or any other time point after sciatic nerve crush injury
among the two mice groups (Figure 2C).
Electrophysiological properties of the sciatic nerves were
evaluated by measurements of sensory and motor nerve
conduction velocity (SNCV and MNCV, respectively) at 29 days
post nerve damage, as a terminal endpoint. Nerves from naïve
SC-p75NTR-KO mice and littermate controls displayed identical
SNCV (Figure 2D) and MNCV (Figure 2E). As expected, SNCV
and MNCV were significantly reduced following the injury.
However, although we did not detect any difference in post-injury
SNCV between SC-p75NTR-KO mice and littermate controls,
SC-p75NTR-KO mice exhibited a further 36% reduction of post-
injury MNCV relative to littermate controls (Figure 2F), pointing
toward ion leakage or/and structural defects in the largest
myelinated axons.
Conditional Deletion of p75NTR in
Schwann Cells Has No Impact on
Peripheral Myelination or Axon
Regeneration Following Nerve Injury
The observation of decreased MNCV in the injured SC-p75NTR-
KO mouse model could be due to variation in Schwann
cell remyelination of the damaged axons since appropriate
re-myelination after peripheral nerve injury has previously
been attributed to p75NTR (Song et al., 2006; Tomita et al.,
2007). We therefore evaluated nerve fiber morphology in semi-
thin cross-sections of sciatic nerves using light microscopy.
Representative images of sciatic nerves from SC-p75NTR-KO
and littermate controls, 15 and 29 days after injury, together
with respective non-lesioned nerves (contralateral sham) are
illustrated in Figure 3A.
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FIGURE 2 | Sensorimotor phenotypic analysis before and after sciatic nerve crush injury. (A) Mechanical nociceptive functional recovery evaluated using the Von
Frey filaments before and 1, 7, 14, 21, and 28 days after nerve injury. Significant difference noticed between contralateral sham and injured paw at 1- and 21-days
post-lesion in the SC-p75NTR-KO group, as consequence of nerve injury (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001). (B) Nociception evaluated with the Hargreaves test
at baseline (time = 0), 1, 7, 14, 21, and 28 days after nerve crush injury; (∗p < 0.05, ∗∗p < 0.01). (C) Locomotor function recovery assessed by walking tract analysis
and calculation of SFI at pre-treatment (time = 0), 1, 7, 14, 21, and 28 days after nerve crush injury. Nerve conduction velocity analysis of sural (sensory) (D) and
sciatic (motor) (E) nerves in naïve SC-p75NTR-KO and control littermates (n = 6 mice per genotype). (F) Nerve conduction velocity measurements in both genotypes
29 days after injury (∗∗∗p < 0.001; n = 6 SC-p75NTR-KO and n = 8 littermates).
Naïve sciatic nerves from SC-p75NTR-KO mice appeared
normal, with axons of various diameters present in proportions
that appeared similar to those observed in littermate controls and
with similar total numbers of myelinated axons (Figures 3A,B).
Features of myelinated axonal degeneration consistent with
axonal loss were observed in both SC-p75NTR-KO and littermate
controls after injury, with a similar decrease in axon number
(Figure 3B) in mice of both genotypes, however, only statistically
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FIGURE 3 | Continued
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FIGURE 3 | Ablation of p75NTR in Schwann cells has no impact on re-myelination after nerve injury. (A) Representative light microscopy images of toluidine-blue
stained semithin transverse sections of sham contralateral and distal stumps from crush injured nerves, 15- and 29-days post-lesion. Scale bar 20 µm. (B–G)
Histograms obtained from the morphometrical analysis of the myelinated fibers. (B) Total number of myelinated fibers, (C) axon diameter, (D) fiber diameter, (E)
myelin thickness, and (F) g-ratio. Scatter plots showing g-ratio of individual myelinated axons as a function of axon diameter in contralateral shams (G) or injured
nerves at time points of 15 (H) and 29 days post lesion (I). Numbers for quantifications were as follows: n = 11 sham, n = 6 at 15 days, and n = 6 at 29 days for
SC-p75NTR-KO; n = 9 sham, n = 3 at 15 days, and n = 6 at 29 days for littermates.
different in the SC-p75NTR-KO mice. Mean of axonal diameter
(Figure 3C), fiber diameter (Figure 3D) or myelin thickness
(Figure 3E) were unchanged between genotypes both before
and following crush injury, but with an injury effect over time,
compared with the respective shams, as expected. Quantification
of acquired light microscopy images (with about 100 fibers
analyzed per animal) revealed no differences in averaged g-ratios
(Figure 3F) or in g-ratios of individual fibers vs. axon diameters,
as illustrated by scatter plots of sham and injured nerves, 15 or
29 days after damage (Figures 3G–I).
Proceeding with ultrastructural EM analysis of sciatic nerve
transverse sections, we found that the uninjured contralateral
nerve of both SC-p75NTR-KO and control mice was dominated
by large and medium-sized myelinated axons. Unmyelinated
axons (C-fibers) occurred in large groups embedded in Schwann
cells, forming Remak bundles (Figure 4A, left panel). The
endoneurium contained several blood vessels, fibroblasts, and
a few mast cells and macrophages. No variance in C-fiber
density was observed between the two mice cohorts (Figure 4B).
Pathology was evident in the injured ipsilateral side of mice of
both genotypes 15 days after crush, with most large myelinated
axons being absent and several medium-sized remyelinated
axons present in the endoneurium (Figure 4C). At days
15 and 29 post injury we observed myelin debris, multi-
vesicular bodies (MVB) and osmophilic and osmophobic fat
droplets in the perineurium, endoneurium, Schwann cells,
macrophages, fibroblasts and pericytes in all injured nerves.
Segmental demyelination of the internodal length and paranode
(Figure 4D) was a prominent feature of injured nerves from
both WT and SC-p75NTR-KO mice. Unmyelinated axons were
very sparse and predominantly appeared solitary rather than in
high numbers in Remak bundles in the Schwann cell cytoplasm
(Figure 4A, right panel). No obvious morphological differences
were found between control littermates and SC-p75NTR-KO
mice; however, although not statistically significant, the mean
C-fiber density in SC-p75NTR-KO mice tended to be slightly
decreased compared to that of littermate controls, 29 days after
injury (Figure 4B). This result suggests that lack of p75NTR
expression in Schwann cells can possibly alter their molecular
signaling profile, affecting glial-axon communication and slowing
down the C-fiber regenerative process.
DISCUSSION
In this study, to elucidate the in vivo function of p75NTR
in Schwann cells during re-myelination and regeneration after
peripheral nerve injury, we generated a new mouse model
for the conditional deletion of p75NTR in Schwann cells.
Through functional testing, morphological and morphometrical
analyses of SC-p75NTR-KO mice, we found that ablation of
p75NTR in Schwann cells correlated with a reduced motor nerve
conduction velocity but had no impact regarding remyelination
or axonal growth after sciatic nerve crush injury.
p75NTR is widely expressed in the nervous system during
development and has even been considered as a neural crest
marker (Wislet et al., 2018). Although p75NTR, also called NGF
receptor, has no intrinsic catalytic activity, it interacts and
modulates the function of TrkA, TrkB, and TrkC, providing
substantial cellular and molecular diversity for regulation of
neuron survival, neurogenesis, immune responses and processes
that support neural function (McGregor and English, 2019). In
Schwann cells, p75NTR is expressed by the immature type during
development and remains being expressed by the mature non-
myelinating Schwann cells in the adult. In contrast, myelinating
Schwann cells are not immunoreactive for p75NTR (Jessen and
Mirsky, 2005). Because p75NTR is highly down-regulated as the
nervous system matures, a powerful tool to induce expression
of this receptor is the dedifferentiation of Schwann cells by
induced nerve injury. Several reports demonstrated dramatic
upregulation of p75NTR in response to injury or disease, in both
the PNS and CNS (Meeker and Williams, 2015). However, these
previous studies focusing on the roles of p75NTR in development
and nerve regeneration have utilized the complete p75NTR KO
mouse model, resulting in loss of p75NTR in both Schwann cells
as well as in a DRG neuron subpopulation (Lee et al., 1992; von
Schack et al., 2001).
Two complete p75NTR KO models have been developed,
both of which demonstrate a dramatic PNS phenotype with
approximately 50% reduction in neuron/myelinated axon
number as well as reduced myelination of the remaining axons.
The first model was constructed by deleting exon III of the
Ngfr gene (Lee et al., 1992), however, it later turned out that
this model produces an alternatively spliced isoform of p75NTR
(s-p75NTR), producing a protein that lacks the portion of the
extracellular domain responsible for neurotrophin binding but
with its intracellular death-signaling moiety intact (Murray et al.,
2003). Complicating the picture, it appears that the genetic
background of the mouse also impacts on the phenotype as
expression of the s-p75NTR splice variant demonstrated a strain
dependent expression level (Naumann et al., 2002). This finding
triggered the development of another KO model, the exon
IV KO model (p75NTRExonIV) which does not express the
s-p75NTR variant. The p75NTRExonIV mice display a more
severe phenotype than the previous p75NTRexonIII mutants,
including a larger reduction in the number of DRG neurons
and Schwann cells, vascular system defects, and approximately
40% of p75NTRExonIV mice do not survive beyond the perinatal
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FIGURE 4 | Trend toward decreased C-fiber density in injured nerves from mice lacking Schwann cell p75NTR expression. (A) Representative images of ultrathin
transverse sciatic nerve sections from sham contralateral nerves (left panel) and 29 days post injury distal stumps (right panel) of the two experimental groups.
Arrowheads identify C-fibers. Scale bar 2 µm. (B) Density of C-fibers expressed as number of unmyelinated axons per square millimeter (n/mm2) Numbers for
quantifications were as follows: n = 12 sham, n = 6 at 15 days, and n = 4 at 29 days for SC-p75NTR-KO; n = 9 sham, n = 3 at 15 days, and n = 4 at 29 days for
littermates. (C) Electron micrographs showing re-myelinated fibers (asterisk) in both SC-p75NTR-KO and control WT littermates, 15 days after sciatic nerve crush
injury. (D) Representative pictures of segmental demyelination observed in both strains after sciatic nerve injury, both at internodal and paranodal regions.
Scale bar 5 µm.
period (von Schack et al., 2001). It was, however, soon determined
that the p75NTRExonIV model express a p75NTR gene product
encoding a truncated protein with an apparent molecular weight
of 26 kDa (Paul et al., 2004). The utilization of mouse models
with a general targeting profile (including both neurons and
Schwann cells) combined with the incomplete nature of the
p75NTR deletions and the difficulties in delineating the impact of
the genetic background, all complicates a rigorous interpretation
of previous findings on the role of p75NTR in specific PNS
cell subpopulations.
In the present study, the conditional deletion of p75NTR
in Schwann cells is driven by the P0 promotor, expressed in
Schwann cell precursors early in development (around E14),
thus silencing p75NTR expression in both myelinating and
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non-myelinating Schwann cells types (Feltri et al., 1999). Several
studies support a key role for p75NTR in the myelination
process (Chan et al., 2001; Cosgaya et al., 2002; Tolwani
et al., 2004). Surprisingly, our present results demonstrate
that depleting the myelinating Schwann cell subpopulation of
p75NTR during the myelination process does not compromise
myelin sheet formation nor motor function in the adult
naïve SC-p75NTR-KO mice.
Boskovic et al. (2014) have not detected any splice variant
at the transcriptional or protein levels when developing the
p75in/in mouse line used in our study. The fact that we see
no neuronal phenotype (reduction in axon number) supports
that the model is “clean” from the splice variants found in
the p75NTRExonIII and p75NTRExonIV models (which display
dramatic PNS phenotypes). Besides neurons and Schwann cells,
other cells types have been reported to express p75NTR such as
macrophages (Wong et al., 2010), endothelial cells (Tanaka et al.,
2004), white fatty tissue (Peeraully et al., 2004), and fibroblasts
(Palazzo et al., 2011). Whether such cell types in the sciatic nerve
also express p75NTR remains to be determined but this (along
with continued axonal expression) may explain the remaining
expression of p75NTR in the sciatic nerve upon deletion of
Schwann cell p75NTR. Our in vitro cultures of mouse Schwann
cells reveal that these cells are indeed devoid of p75NTR (and
positive for mCherry, confirming Cre-activity in these cells).
Due to the pleiotropic roles of p75NTR, it is not surprising
that its role in regeneration following nerve injury has been
controversial. While Song et al. observed reduced regeneration
in the p75NTR KO model, work from Scott and Ramer reported
that p75NTR expressed by Schwann cells is actually deleterious for
nerve regeneration. The mechanism suggested was that increased
Schwann cell p75NTR expression might sequester endogenous
neurotrophins and thus reduce their availability for axonal Trk
signaling (Scott and Ramer, 2009); a notion supported by the
enhanced regeneration of injured peripheral motor axons in
mice lacking the neurotrophin-binding domain of p75NTR (Boyd
and Gordon, 2001). In contrast with this observation, another
study using transplantation of p75NTR-deficient Schwann cells
to injured nerves from nude mice found that a lack of glial
p75NTR had a negative impact in the regeneration of motor
neurons (Tomita et al., 2007). This model is closer to ours in
terms of Schwann cell selectivity, however, the fact that they used
nude mice may complicate comparisons since other mechanisms
might have been activated by the inhibited immune system,
which consequently altered the Schwann cell-axon signaling
profile. Nevertheless, like in our study, no difference in the total
number of myelinated fibers and fiber density was observed, but
a significant decrease in motor nerve conduction velocity was
detected (Tomita et al., 2007). Myelin affects nerve conduction
velocity and in contrast with our observations, p75NTR null
Schwann cell-grafted mice displayed a significant decrease in
myelin thickness (Tomita et al., 2007), which could explain
the altered motor nerve conduction profile. Yet, this is not
always the case; for example, in mouse models of diabetic
neuropathy, decreased nerve conduction velocity is often not
accompanied by demyelination or fiber loss (Hinder et al., 2017).
The reason why this happens is not really understood, but
several factors are known to alter nerve conduction velocity
in addition to motor axon loss or decreased myelin thickness,
such as length of nodal gap (Arancibia-Cárcamo et al., 2017),
nodal axonal hydropic swelling (Kolaric et al., 2013), distribution
of sodium channels, defects in the Na+/K+ ATPase (Freeman
et al., 2016), impaired Schwann cell exocytosis (Chen et al.,
2012), mitochondrial fiber deficiency (Viader et al., 2011; Bala
et al., 2018) or reduced endoneurial nutritive blood flow (Coppey
et al., 2001). We speculate that in our model, the segmental
demyelination of the internodal length and paranode in the SC-
p75NTR-KO injured nerves leads to leakage of ions from the axons
culminating with slower motor nerve conduction velocities,
throughout a mechanism that still needs further clarification
but that might involve alterations in axonal sodium channels,
molecular signaling or composition, and differential regulation
of myelin production and repair (Taveggia et al., 2010). Thus, it
is fair to speculate that p75NTR might have a role in internode
length and/or nodal composition after injury. In line with this,
the regulation of neuronal form and function by Schwann cells
has been found to be mediated by different forms of intercellular
communication (Orellana et al., 2012; Samara et al., 2013), and
recent findings suggest the occurrence of lateral molecular cargo
transfer to axons mediated by exosomes secreted from Schwann
cells (Lopez-Verrilli and Court, 2012). This mechanism has
been poorly explored to date, but recent papers have described
Schwann cell secreted exosomes being incorporated into axons
and increasing neurite sprouting (Court et al., 2008; Lopez-
Verrilli et al., 2013). These findings open a new dimension to the
degree of intercellular interactions and the idea of a functional
nerve syncytium. Deletion of p75NTR in Schwann cells had no
apparent effect on basic sciatic nerve structure (developmental
effects) including the number or density of myelinated and
unmyelinated axons, myelination (g-ratio), nor on regeneration
upon crush injury. This is somewhat surprising, considering
the observations that p75NTR is highly expressed in Schwann
cells during development and the regenerative process. It is now
accepted that neurons can synthesize proteins locally in axons
and dendrites, and that this localized translation is required for
neuronal homeostasis (Jung et al., 2012). Perhaps neurons/axons
develop compensatory mechanisms to balance and counteract the
absence of p75NTR Schwann cell expression, altering e.g., vesicle
cargo and the glial-axon communication process?
A mouse line carrying a conditional knockout allele
for p75NTR (p75NTRExonIV–VI) was previously generated to
investigate its functions in DRG neurons in vivo (Bogenmann
et al., 2011). The allele was designed such that a complete and
conditional knockout could be achieved without the molecular
complexities observed in mice with either the p75NTRExonIII
(von Schack et al., 2001) or the p75NTRExonIV allele (Paul
et al., 2004). While otherwise normal in size (contrasting the
ExonIV model), p75NTRExonIV–VI mice displayed an abnormal
hind limb “clenching” phenotype similar to that seen in
p75NTRExonIII and p75NTRExonIV mice, suggesting that this
common neuropathic phenotype was at least in part due to
the impaired function of p75NTR specifically in neural crest
cells. In addition, there were far fewer small (unmyelinated and
lightly myelinated) diameter axon bundles in the mutant nerves
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(Bogenmann et al., 2011). Another study using stereological
counting demonstrated that p75NTRExonIII mice display a
52% loss of DRG neurons, with the loss of small nociceptors
being larger than the loss of large proprioceptors (57 vs. 39%,
respectively), and these data were supported by similar results
obtained by nerve fiber counts of unmyelinated vs. myelinated
axons (Gjerstad et al., 2002). This could either reflect that
p75NTR expression occurs predominantly in small nociceptors
or that it is most important for non-myelinating Schwann cells
to support axon survival, homeostasis and growth. The fact
that non-myelinating Schwann cells express p75NTR in adult
mice in contrast to the myelinating type also fits well within
this observation. Recently, one study indicated that neuron-
specific deletion of p75NTR at E12.5 was insufficient to impact
on neuronal survival during embryogenesis whereas 20% of DRG
neurons were lost in adult mice, suggesting that neuronal p75NTR
functions only postnatally in sensory neuron diversification
(Chen et al., 2017). In our Schwann cell conditional p75NTR
KO mouse model, we found a trend for reduced preservation of
unmyelinated fibers in the sciatic nerve 29 days after injury. The
crush injury model is a model of axonotmesis, in which axons
are disrupted but the connective tissue and the Schwann cell
basal lamina remains intact. When this crush model is applied in
rodents, axonal regeneration is remarkably efficient and function
is restored in 3–4 weeks (Jessen et al., 2015). Thus, it would
be predictable that potential early or late differences regarding
remyelination and axon regeneration would be detected by
evaluation of nerve morphology and morphometry at both 15-
and 29-days post-crush injury. Nevertheless, whether different
outcomes could have been found at even earlier time points after
nerve injury remains to be investigated.
In summary, the influence that p75NTR exerts upon the
regenerative and remyelinative processes in the PNS remain
controversial, with conflicting findings in DRG- and motor
neurons (Tomita et al., 2007; Scott and Ramer, 2009) and a lack
of clarity around Schwann cell and neuronal influences. Through
utilization of a Schwann cell specific p75NTR knockout strategy,
we demonstrate that Schwann cell expression of p75NTR is not
important for either sciatic nerve regeneration and remyelination
following crush injury, but does exert important influences upon
recovery of motor nerve function.
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